Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 89,738 |
|
|||||
| News | - | ||||||
| Day High | 0.9274 | Low High |
|||||
| Day Low | 0.8702 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MiNK Therapeutics Inc | INKT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0259 | 2.90% | 0.9199 | 14:47:29 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.889 | 0.8702 | 0.9274 | 0.894 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 574 | 89,738 | $ 0.8922818 | $ 80,072 | - | 0.75 - 3.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:52:27 | 77 | $ 0.9197 | USD |
MiNK Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 31.76M | 34.52M | - | 0 | -22.46M | -0.65 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MiNK Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INKT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.90 | 0.96 | 0.861 | 0.8899548 | 37,986 | 0.0199 | 2.21% |
| 1 Month | 0.92 | 1.90 | 0.861 | 1.32 | 200,818 | -0.0001 | -0.01% |
| 3 Months | 0.89 | 1.90 | 0.78 | 1.18 | 100,976 | 0.0299 | 3.36% |
| 6 Months | 1.05 | 1.90 | 0.75 | 1.11 | 71,638 | -0.1301 | -12.39% |
| 1 Year | 2.11 | 3.34 | 0.75 | 1.50 | 98,758 | -1.19 | -56.40% |
| 3 Years | 12.04 | 22.155 | 0.75 | 3.08 | 113,315 | -11.12 | -92.36% |
| 5 Years | 12.04 | 22.155 | 0.75 | 3.08 | 113,315 | -11.12 | -92.36% |
MiNK Therapeutics Description
| MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. |
